A detailed history of Acadian Asset Management LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Acadian Asset Management LLC holds 46,012 shares of ACIU stock, worth $123,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,012
Holding current value
$123,312
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.99 - $4.2 $137,575 - $193,250
46,012 New
46,012 $172,000
Q1 2023

May 11, 2023

BUY
$2.13 - $2.49 $8,189 - $9,574
3,845 New
3,845 $8,000
Q4 2021

Feb 10, 2022

SELL
$4.83 - $7.56 $517,259 - $809,623
-107,093 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$6.2 - $8.34 $727,867 - $979,099
-117,398 Reduced 52.3%
107,093 $717,000
Q2 2021

Aug 11, 2021

SELL
$6.04 - $8.37 $313,651 - $434,645
-51,929 Reduced 18.79%
224,491 $1.78 Million
Q1 2021

May 11, 2021

SELL
$5.32 - $8.96 $2.05 Million - $3.46 Million
-386,092 Reduced 58.28%
276,420 $2.1 Million
Q4 2020

Feb 11, 2021

SELL
$4.47 - $5.58 $855,414 - $1.07 Million
-191,368 Reduced 22.41%
662,512 $3.43 Million
Q3 2020

Nov 09, 2020

BUY
$4.78 - $9.06 $405,477 - $768,541
84,828 Added 11.03%
853,880 $4.17 Million
Q2 2020

Aug 12, 2020

BUY
$6.57 - $8.3 $139,750 - $176,549
21,271 Added 2.84%
769,052 $5.18 Million
Q1 2020

May 11, 2020

BUY
$4.24 - $9.89 $1.81 Million - $4.22 Million
426,542 Added 132.78%
747,781 $5.16 Million
Q4 2019

Feb 06, 2020

BUY
$4.56 - $8.78 $791,410 - $1.52 Million
173,555 Added 117.52%
321,239 $2.74 Million
Q3 2019

Nov 07, 2019

BUY
$4.8 - $5.89 $284,116 - $348,634
59,191 Added 66.89%
147,684 $729,000
Q2 2019

Aug 08, 2019

BUY
$4.72 - $5.88 $417,686 - $520,338
88,493 New
88,493 $492,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $224M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.